These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 19347085)
1. Vitiligo as an adverse reaction to topical diphencyprone. Pan JY; Theng C; Lee J; Goh BK Ann Acad Med Singap; 2009 Mar; 38(3):276-7. PubMed ID: 19347085 [No Abstract] [Full Text] [Related]
2. Vitiligo as a reaction to topical treatment with diphencyprone. Hatzis J; Gourgiotou K; Tosca A; Varelzidis A; Stratigos J Dermatologica; 1988; 177(3):146-8. PubMed ID: 3169339 [TBL] [Abstract][Full Text] [Related]
3. Vitiligo and topical allergens. Orecchia G; Perfetti L Dermatologica; 1989; 179(3):137-8. PubMed ID: 2591620 [No Abstract] [Full Text] [Related]
6. Topical immunotherapy with diphencyprone in the treatment of extensive and/or long-lasting alopecia areata. Firooz A; Bouzari N; Mojtahed F; Pazoki-Toroudi H; Nassiri-Kashani M; Davoudi M; Dowlati Y J Eur Acad Dermatol Venereol; 2005 May; 19(3):393-4. PubMed ID: 15857483 [No Abstract] [Full Text] [Related]
7. Generalized urticaria with use of diphencyprone in the treatment of warts. Culp BL; Wells MJ J Drugs Dermatol; 2007 May; 6(5):529-30. PubMed ID: 17679188 [TBL] [Abstract][Full Text] [Related]
9. Response rates of cutaneous melanoma metastases to diphencyprone: A meta-analysis. Lôbo MM; Calsavara VF; Ricci BV; Lopes Pinto CA; Bertolli E; Duprat Neto JP J Am Acad Dermatol; 2020 Dec; 83(6):1812-1813. PubMed ID: 32289400 [No Abstract] [Full Text] [Related]
10. TH17 is involved in the remarkable regression of metastatic malignant melanoma to topical diphencyprone. Martiniuk F; Damian DL; Thompson JF; Scolyer RA; Tchou-Wong KM; Levis WR J Drugs Dermatol; 2010 Nov; 9(11):1368-72. PubMed ID: 21061759 [TBL] [Abstract][Full Text] [Related]
11. [Treatment of alopecia areata of the eyebrow with diphenylcyclopropenone and its possible risks]. Lutz G; Kreysel HW Z Hautkr; 1989 Oct; 64(10):898-900. PubMed ID: 2588751 [TBL] [Abstract][Full Text] [Related]
12. Topical immunotherapy with diphenylcyclopropenone in vitiligo: a preliminary experience. Aghaei S; Ardekani GS Indian J Dermatol Venereol Leprol; 2008; 74(6):628-31. PubMed ID: 19171989 [TBL] [Abstract][Full Text] [Related]
13. Provoking factors, including chemicals, in Dutch patients with vitiligo. Vrijman C; Hosseinpour D; Bakker JG; Wolkerstorfer A; Bos JD; van der Veen JP; Luiten RM Br J Dermatol; 2013 May; 168(5):1003-11. PubMed ID: 23252956 [TBL] [Abstract][Full Text] [Related]
15. Treatment of molluscum contagiosum with topical diphencyprone therapy. Kang SH; Lee D; Hoon Park J; Cho SH; Lee SS; Park SW Acta Derm Venereol; 2005; 85(6):529-30. PubMed ID: 16396805 [No Abstract] [Full Text] [Related]